Clinical Trial Update: Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

View source ↗

Summary

A completed registry study evaluating the use of etanercept in rheumatoid arthritis patients in clinical practice in Taiwan, sponsored by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED